UBS analyst Patrick Rafaisz upgraded Forbo Holding AG (FORN:SW) stock from Neutral to Buy, despite lowering the price target ...

UBS has downgraded Regeneron Pharmaceuticals Inc (NASDAQ:REGN) to "Neutral" from "Buy" given uncertainty around its key Eylea franchise. Brokerage slashed price target to $738 from $1130.

UBS lowered the firm’s price target on Coca-Cola (KO) to $72 from $82 and keeps a Buy rating on the shares. Sentiment around Consumer Staples ...

UBS analyst Peter Grom lowered the firm’s price target on Molson Coors (TAP) to $58 from $60 and keeps a Neutral rating on the shares.

Investing.com -- UBS downgraded Saint Gobain (EPA: SGOB) to Neutral from Buy in a note Thursday, citing limited upside ...

UBS has issued a cautionary note regarding Trump's tariffs, asserting that they pose a risk to the Fed’s 2% inflation target.

Investing.com -- UBS analysts have reaffirmed their bullish stance on Continental (ETR: CONG) stock, emphasizing the ...

Deutsche Bank analyst Benjamin Goy raised the firm’s price target on UBS (UBS) to CHF 29 from CHF 27 and keeps a Hold rating on the shares. TipRanks is the most comprehensive data set of sell ...

Oil prices have risen to a five-month high on concerns that the ... other than personal viewing, without UBS's prior written permission is strictly prohibited.

Novo Nordisk's U.S.-listed and domestic shares rose Wednesday after analysts from UBS upgraded the Danish drugmaker's stock ...

A decision by US President-elect Donald Trump to ramp up tariffs gradually once he takes office would be “problematic” for ...